CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ)

$1.45 0.05 (3.5714%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 76

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ) News Sources

Cellectar (CLRB) Phase 2b Data Shows Durable Responses in Waldenström Macroglobulinemia

05-05-2026

advfn.com

Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026

11-05-2026

yahoo.com

Cellectar Biosciences Inc (CLRB) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...

14-05-2026

yahoo.com

Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting

01-06-2026

yahoo.com

Cellectar Biosciences (CLRB) Stock Fair Value Moves Lower As Analysts Weigh Execution Risk

11-07-2026

yahoo.com

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

15-07-2026

yahoo.com

Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026

30-07-2026

yahoo.com

Cellectar Biosciences Inc (CLRB) (Q2 2026) Earnings Call Highlights: Strong Clinical Data and ...

17-08-2026

yahoo.com

Cellectar Biosciences (CLRB) Q2 2026 Earnings Call Transcript

20-08-2026

fool.com

Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia

29-09-2026

yahoo.com

CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ) Sentiment Trend

0 25 50 75 100 75 64 88 74 81 76 64 91 83 65 05-05-2026 11-05-2026 14-05-2026 01-06-2026 11-07-2026 15-07-2026 30-07-2026 17-08-2026 20-08-2026 29-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ) FAQs

toggle

What is the current price of CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ)?

The current price of CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ) is $1.45.


toggle

CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ) absolute price change since previous trading day?

The absolute price change of CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ) since the previous trading day is $0.05.


toggle

CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ) percentage price change since previous trading day?

The percentage price change of CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ) since the previous trading day is 3.5714%.


toggle

What is the most recent average sentiment score for CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ)?

The most recent average sentiment score for CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ) is 76 out of 100.


toggle

What is the most recent average sentiment for CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ)?

The most recent sentiment for CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ) is .


SEC-8K** Filing Available For CELLECTAR BIOSCIENCES INC (CLRB:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.